[
  {
    "timestamp": "2025-07-03T22:47:39.058382",
    "function_name": "process_cells",
    "parameters": {
      "cell_type": "Immune cell"
    },
    "success": true,
    "error": null,
    "result_summary": "Annotation complete for Immune cell.\n\u2022 Annotation Result: Analysis: group_to_cell_type = {'0': 'Mononuclear phagocyte', '1': 'T cell', '2': 'T cell', '3': 'T cell', '4': 'Mononuclear phagocyte', '5': 'Mononuclear phagocyte', '6': 'Mononuclear phagocyte', '7': 'Mononuclear phagocyte', '8': 'Mononuclear phagocyte', '9': 'Megakaryocyte', '10': 'Mononuclear phagocyte', '11': 'Mononuclear phagocyte', '12': 'Mononuclear phagocyte', '13': 'Natural killer cell', '14': 'B cell', '15': 'Mononuclear phagoc"
  },
  {
    "timestamp": "2025-07-03T22:47:46.769425",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "B cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'dea_results': [{'category': 'p1_post', 'significant_genes': [], 'description': 'Post-treatment sample from patient 1'}, {'category': 'p6_pre', 'significant_genes': ['CD79A', 'MS4A1', 'RPS23', 'BANK1', 'RPS5', 'RPS27', 'RPL19', 'RPS6', 'RPL18A', 'RPL32', 'RPS8', 'RPL30', 'CD37', 'CD79B', 'RPL36', 'IGHM', 'RPL11', 'RPL8', 'RPL13', 'IGKC', 'RPS27A', 'RPS18', 'RPS21', 'RPS13', 'LINC00926', 'RPL5', 'KLF2', 'RPL9', 'TXNIP', 'EEF1B2', 'VPREB3', 'RPL7A', 'FAU', 'RPL23A', 'CD83', 'RPL21', 'RPL34', 'JUN"
  },
  {
    "timestamp": "2025-07-03T22:47:55.094867",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'dea_results': [{'category': 'p1_pre', 'significant_genes': ['MALAT1', 'PTPRC', 'SMCHD1', 'SRSF7', 'TNFAIP3', 'FUS', 'ADGRE5', 'BTG1', 'CCNL1', 'BCL11B', 'LINC01578', 'ETS1', 'SF1', 'STAT4', 'ZFP36L2', 'STK17B', 'DDX24', 'TSPYL2', 'IL7R', 'CELF2', 'CD69', 'SLC2A3', 'BRD2', 'EIF1', 'CNOT6L', 'AKAP13', 'RBM39', 'PARP8', 'H3F3B', 'CHD2', 'DDX3X', 'OGT', 'SARAF', 'TSC22D3', 'GNG2', 'CD44', 'EML4', 'LINC-PINT', 'CEMIP2', 'ITK', 'SYTL3', 'SYNE2', 'JUND', 'TXNIP', 'POLR2A', 'STK17A', 'SRSF3', 'STK4', "
  },
  {
    "timestamp": "2025-07-03T22:47:55.095559",
    "function_name": "conversational_response",
    "parameters": {
      "comparison": "B cell vs T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "I'm ready to help with your single-cell RNA-seq analysis using intelligent cell type hierarchy management. What would you like to explore?"
  },
  {
    "timestamp": "2025-07-03T22:48:05.250938",
    "function_name": "final_question",
    "parameters": {
      "original_question": "Compare the differential expressive genes between B cell and T cell. Do not do plotting."
    },
    "success": true,
    "error": null,
    "result_summary": "To compare the differential expression of genes between B cells and T cells based on the provided analysis results, we can examine the significant genes identified in each cell type across different conditions.\n\n### B Cell Differential Expression Analysis:\n- **p1_post**: No significant genes were identified.\n- **p7_pre**: 21 significant genes were upregulated. Notable genes include VPREB3, LINC01781, and IGHGP.\n- **p6_post**: 100 significant genes were identified, with 99 upregulated. Key upregu"
  },
  {
    "timestamp": "2025-07-03T22:49:49.932798",
    "function_name": "display_gsea_dotplot",
    "parameters": {},
    "success": false,
    "error": "[Errno 2] No such file or directory: 'gsea_plots/gsea_plot_data.csv'",
    "result_summary": null
  },
  {
    "timestamp": "2025-07-03T22:49:54.415506",
    "function_name": "display_gsea_dotplot",
    "parameters": {},
    "success": false,
    "error": "[Errno 2] No such file or directory: 'gsea_plots/gsea_plot_data.csv'",
    "result_summary": null
  },
  {
    "timestamp": "2025-07-03T22:49:59.283760",
    "function_name": "display_gsea_dotplot",
    "parameters": {},
    "success": false,
    "error": "[Errno 2] No such file or directory: 'gsea_plots/gsea_plot_data.csv'",
    "result_summary": null
  },
  {
    "timestamp": "2025-07-03T22:51:52.536362",
    "function_name": "perform_enrichment_analyses",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'formatted_summary': '\ud83d\udd2c Enrichment Analysis Results for T cell\\n============================================================\\n\\n\ud83d\udcca Analysis Parameters:\\n  \u2022 Log FC threshold: 1.0\\n  \u2022 P-value threshold: 0.05\\n  \u2022 Analyses performed: reactome, go, kegg, gsea\\n  \u2022 Condition-specific analysis: Yes\\n\\n\ud83c\udf10 FULL DATASET ANALYSIS\\n  \u2022 Number of significant genes: 93\\n\\n  \u2022 REACTOME Results:\\n    1. Generation of second messenger molecules (p-value: 3.9759908881188855e-09)\\n       Genes: \\n    2. Immune S"
  },
  {
    "timestamp": "2025-07-03T22:52:00.476036",
    "function_name": "final_question",
    "parameters": {
      "original_question": "What can we find from T cell's gsea results? Do not do plotting."
    },
    "success": true,
    "error": null,
    "result_summary": "The Gene Set Enrichment Analysis (GSEA) results for T cells reveal several significant pathways and biological processes that are enriched, providing insights into the functional roles and potential mechanisms active in these cells.\n\n1. **Reactome Pathways**: The analysis identified significant enrichment in pathways such as \"Generation of second messenger molecules\" (p=3.98e-09), \"Immune System\" (p=1.01e-08), and \"Adaptive Immune System\" (p=4.67e-07). These findings suggest that T cells are act"
  },
  {
    "timestamp": "2025-07-03T22:52:04.498421",
    "function_name": "perform_enrichment_analyses",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'status': 'cached_result', 'file_path': 'schatbot/enrichment/reactome/results_summary_T cell.csv', 'data':                 Term_ID                                              Term  ...  calculated_intersection_count  avg_log2fc\n0     REAC:R-HSA-202433          Generation of second messenger molecules  ...                              8    4.171467\n1     REAC:R-HSA-168256                                     Immune System  ...                             34    3.270481\n2    REAC:R-HSA-1280218   "
  },
  {
    "timestamp": "2025-07-04T09:00:35.886862",
    "function_name": "process_cells",
    "parameters": {
      "cell_type": "Immune cell"
    },
    "success": true,
    "error": null,
    "result_summary": "Annotation complete for Immune cell.\n\u2022 Annotation Result: Analysis: group_to_cell_type = {'0': 'Mononuclear phagocyte', '1': 'T cell', '2': 'T cell', '3': 'T cell', '4': 'Mononuclear phagocyte', '5': 'Mononuclear phagocyte', '6': 'Mononuclear phagocyte', '7': 'Mononuclear phagocyte', '8': 'Mononuclear phagocyte', '9': 'Mononuclear phagocyte', '10': 'Mononuclear phagocyte', '11': 'Mononuclear phagocyte', '12': 'Mononuclear phagocyte', '13': 'Natural killer cell', '14': 'B cell', '15': 'Mononuclea"
  },
  {
    "timestamp": "2025-07-04T09:00:43.533052",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "B cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'dea_results': [{'category': 'p1_post', 'significant_genes': [], 'description': 'Post-treatment sample from patient 1'}, {'category': 'p6_pre', 'significant_genes': ['CD79A', 'MS4A1', 'RPS23', 'BANK1', 'RPS5', 'RPS27', 'RPL19', 'RPS6', 'RPL18A', 'RPL32', 'RPS8', 'RPL30', 'CD37', 'CD79B', 'RPL36', 'IGHM', 'RPL11', 'RPL8', 'RPL13', 'IGKC', 'RPS27A', 'RPS18', 'RPS21', 'RPS13', 'LINC00926', 'RPL5', 'KLF2', 'RPL9', 'TXNIP', 'EEF1B2', 'VPREB3', 'RPL7A', 'FAU', 'RPL23A', 'CD83', 'RPL21', 'RPL34', 'JUN"
  },
  {
    "timestamp": "2025-07-04T09:00:51.791118",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'dea_results': [{'category': 'p1_pre', 'significant_genes': ['MALAT1', 'PTPRC', 'SMCHD1', 'SRSF7', 'TNFAIP3', 'FUS', 'ADGRE5', 'BTG1', 'CCNL1', 'BCL11B', 'LINC01578', 'ETS1', 'SF1', 'STAT4', 'ZFP36L2', 'STK17B', 'DDX24', 'TSPYL2', 'IL7R', 'CELF2', 'CD69', 'SLC2A3', 'BRD2', 'EIF1', 'CNOT6L', 'AKAP13', 'RBM39', 'PARP8', 'H3F3B', 'CHD2', 'DDX3X', 'OGT', 'SARAF', 'TSC22D3', 'GNG2', 'CD44', 'EML4', 'LINC-PINT', 'CEMIP2', 'ITK', 'SYTL3', 'SYNE2', 'JUND', 'TXNIP', 'POLR2A', 'STK17A', 'SRSF3', 'STK4', "
  },
  {
    "timestamp": "2025-07-04T09:00:51.792046",
    "function_name": "conversational_response",
    "parameters": {
      "comparison": "B cell vs T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "I'm ready to help with your single-cell RNA-seq analysis using intelligent cell type hierarchy management. What would you like to explore?"
  },
  {
    "timestamp": "2025-07-04T09:01:11.050348",
    "function_name": "final_question",
    "parameters": {
      "original_question": "Compare the differential expressive genes between B cell and T cell. Do not do plotting."
    },
    "success": true,
    "error": null,
    "result_summary": "To compare the differential expression of genes between B cells and T cells, we can examine the specific results from the differential expression analysis (DEA) provided for each cell type.\n\n### T Cell Differential Expression Analysis:\n- Across various conditions (p7_pre, p6_pre, p7_post, p6_post, p1_pre, p1_post), T cells consistently show a high number of upregulated genes, with no downregulated genes reported. \n- Notably, genes such as **CD3E**, **CD3D**, **CD3G**, **CD2**, and **IL7R** are f"
  },
  {
    "timestamp": "2025-07-04T09:04:16.776752",
    "function_name": "perform_enrichment_analyses",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'formatted_summary': '\ud83d\udd2c Enrichment Analysis Results for T cell\\n============================================================\\n\\n\ud83d\udcca Analysis Parameters:\\n  \u2022 Log FC threshold: 1.0\\n  \u2022 P-value threshold: 0.05\\n  \u2022 Analyses performed: reactome, go, kegg, gsea\\n  \u2022 Condition-specific analysis: Yes\\n\\n\ud83c\udf10 FULL DATASET ANALYSIS\\n  \u2022 Number of significant genes: 93\\n\\n  \u2022 REACTOME Results:\\n    1. Generation of second messenger molecules (p-value: 3.9759908881188855e-09)\\n       Genes: \\n    2. Immune S"
  },
  {
    "timestamp": "2025-07-04T09:04:31.769149",
    "function_name": "final_question",
    "parameters": {
      "original_question": "Do GSEA to T cell. Do not do plotting."
    },
    "success": true,
    "error": null,
    "result_summary": "Based on the Gene Set Enrichment Analysis (GSEA) conducted for T cells, several significant pathways and biological processes have been identified, reflecting the functional characteristics and potential roles of T cells in the immune response.\n\n### Key Findings:\n\n1. **Reactome Pathways**:\n   - **Generation of second messenger molecules** (p=3.98e-09): This pathway is crucial for intracellular signaling, which is essential for T cell activation and function.\n   - **Immune System** (p=1.01e-08) a"
  },
  {
    "timestamp": "2025-07-04T09:07:00.749806",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "T cell",
      "gene": "SLAMF6",
      "conditions": [
        "P1",
        "P6",
        "P7"
      ],
      "comparison": "post-treatment vs pre-treatment"
    },
    "success": true,
    "error": null,
    "result_summary": "{'status': 'cached_result', 'file_path': 'schatbot/deg_res/T cell_markers_p7_pre.csv', 'data':       names     scores  logfoldchanges          pvals      pvals_adj\n0      CD69  28.949219        4.231173  2.870588e-184  6.530300e-180\n1   TNFAIP3  27.773293        3.409673  9.119546e-170  6.915352e-166\n2       CD2  27.300630        5.331547  4.169110e-164  1.896862e-160\n3   ZFP36L2  26.965221        2.493037  3.782316e-160  1.282103e-156\n4      CCL5  24.647415        4.369767  3.922587e-134  6.864"
  },
  {
    "timestamp": "2025-07-04T09:07:07.407445",
    "function_name": "final_question",
    "parameters": {
      "original_question": "Regarding the T cells, what change in SLAMF6 expression was observed in the P1,P6,P7 when comparing post-treatment to pre-treatment?"
    },
    "success": true,
    "error": null,
    "result_summary": "Based on the differential expression analysis (DEA) results provided for T cells, we can assess the changes in SLAMF6 expression for patients P1, P6, and P7 when comparing post-treatment to pre-treatment conditions.\n\n1. **Patient P1**:\n   - **Pre-treatment**: SLAMF6 is not listed among the top upregulated genes, indicating it was not significantly upregulated.\n   - **Post-treatment**: SLAMF6 is also not listed among the top upregulated genes, suggesting no significant change in its expression po"
  },
  {
    "timestamp": "2025-07-04T09:09:10.600245",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'status': 'cached_result', 'file_path': 'schatbot/deg_res/T cell_markers_p7_pre.csv', 'data':       names     scores  logfoldchanges          pvals      pvals_adj\n0      CD69  28.949219        4.231173  2.870588e-184  6.530300e-180\n1   TNFAIP3  27.773293        3.409673  9.119546e-170  6.915352e-166\n2       CD2  27.300630        5.331547  4.169110e-164  1.896862e-160\n3   ZFP36L2  26.965221        2.493037  3.782316e-160  1.282103e-156\n4      CCL5  24.647415        4.369767  3.922587e-134  6.864"
  },
  {
    "timestamp": "2025-07-04T09:09:10.610419",
    "function_name": "perform_enrichment_analyses",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": true,
    "error": null,
    "result_summary": "{'status': 'cached_result', 'file_path': 'schatbot/enrichment/reactome/results_summary_T cell.csv', 'data':                 Term_ID                                              Term  ...  calculated_intersection_count  avg_log2fc\n0     REAC:R-HSA-202433          Generation of second messenger molecules  ...                              8    4.171467\n1     REAC:R-HSA-168256                                     Immune System  ...                             34    3.270481\n2    REAC:R-HSA-1280218   "
  },
  {
    "timestamp": "2025-07-04T09:09:10.622887",
    "function_name": "display_enrichment_dotplot",
    "parameters": {
      "cell_type": "T cell"
    },
    "success": false,
    "error": "display_enrichment_dotplot() missing 1 required positional argument: 'analysis'",
    "result_summary": null
  },
  {
    "timestamp": "2025-07-04T09:26:41.817476",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "T cell",
      "condition": "pre-treatment vs post-treatment",
      "patients": [
        "P1"
      ]
    },
    "success": true,
    "error": null,
    "result_summary": "{'status': 'cached_result', 'file_path': 'schatbot/deg_res/T cell_markers_p7_pre.csv', 'data':       names     scores  logfoldchanges          pvals      pvals_adj\n0      CD69  28.949219        4.231173  2.870588e-184  6.530300e-180\n1   TNFAIP3  27.773293        3.409673  9.119546e-170  6.915352e-166\n2       CD2  27.300630        5.331547  4.169110e-164  1.896862e-160\n3   ZFP36L2  26.965221        2.493037  3.782316e-160  1.282103e-156\n4      CCL5  24.647415        4.369767  3.922587e-134  6.864"
  },
  {
    "timestamp": "2025-07-04T09:26:41.829705",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "T cell",
      "condition": "pre-treatment vs post-treatment",
      "patients": [
        "P6"
      ]
    },
    "success": true,
    "error": null,
    "result_summary": "{'status': 'cached_result', 'file_path': 'schatbot/deg_res/T cell_markers_p7_pre.csv', 'data':       names     scores  logfoldchanges          pvals      pvals_adj\n0      CD69  28.949219        4.231173  2.870588e-184  6.530300e-180\n1   TNFAIP3  27.773293        3.409673  9.119546e-170  6.915352e-166\n2       CD2  27.300630        5.331547  4.169110e-164  1.896862e-160\n3   ZFP36L2  26.965221        2.493037  3.782316e-160  1.282103e-156\n4      CCL5  24.647415        4.369767  3.922587e-134  6.864"
  },
  {
    "timestamp": "2025-07-04T09:26:41.839535",
    "function_name": "dea_split_by_condition",
    "parameters": {
      "cell_type": "T cell",
      "condition": "pre-treatment vs post-treatment",
      "patients": [
        "P7"
      ]
    },
    "success": true,
    "error": null,
    "result_summary": "{'status': 'cached_result', 'file_path': 'schatbot/deg_res/T cell_markers_p7_pre.csv', 'data':       names     scores  logfoldchanges          pvals      pvals_adj\n0      CD69  28.949219        4.231173  2.870588e-184  6.530300e-180\n1   TNFAIP3  27.773293        3.409673  9.119546e-170  6.915352e-166\n2       CD2  27.300630        5.331547  4.169110e-164  1.896862e-160\n3   ZFP36L2  26.965221        2.493037  3.782316e-160  1.282103e-156\n4      CCL5  24.647415        4.369767  3.922587e-134  6.864"
  },
  {
    "timestamp": "2025-07-04T09:26:52.634758",
    "function_name": "final_question",
    "parameters": {
      "original_question": "Here is the meta data of the expriment: Seven adult patients with newly diagnosed, MGMT-unmethylated, EGFRvIII-positive glioblastoma underwent a phase 1 study combining systemically infused EGFRvIII\\u2010targeted CAR T cells with pembrolizumab. After surgical resection and hypofractionated radiation (40 Gy in 15 fractions), each patient received up to three cycles of CAR T cells (2 \\u00d7 10^8 cells/dose) co-administered with anti-PD-1, followed by pembrolizumab monotherapy. Safety was monitored by dose-limiting toxicity criteria and clinical adverse\\u2010event grading. Tumors were resected at radiographic progression (7\\u2013179 days post-infusion), providing paired pre- and post-treatment specimens in three patients and post-treatment tissue in four. Data modalities included single-cell RNA sequencing and TCR sequencing on CD45-enriched cells, flow cytometry phenotyping of infusion products with a 30\\u2010marker panel, quantitative PCR for CAR transgene detection, and bulk NGS assessment of EGFRvIII expression. Peripheral blood kinetics were tracked by CAR copies per \\u03bcg DNA. Comparative analyses involved prior recurrent GBM CAR T trials. The design allowed dissection of CAR T-cell infiltration, phenotypic shifts in myeloid and T-cell subsets, and interferon-stimulated signatures correlating with outcomes.  Basing on this information and the analyses we did to answer this question:  Regarding the T cells, what change in SLAMF6 expression was observed in the P1,P6,P7 when comparing post-treatment to pre-treatment? Do not do plotting."
    },
    "success": true,
    "error": null,
    "result_summary": "Based on the differential expression analysis (DEA) performed for T cells in patients P1, P6, and P7, we can address the question regarding changes in SLAMF6 expression post-treatment compared to pre-treatment.\n\nFor patient P1, the DEA results show that 100 genes were significantly upregulated pre-treatment, with top genes including BCL11B, ITK, and IL7R. Post-treatment, 88 genes were significantly upregulated, with top genes being TRAC, CD8A, and BCL11B. However, SLAMF6 was not listed among the"
  }
]